Clinical Advances in the Management of Onychomycosis

Onychomycosis is a common fungal infection of the nail that is most frequently caused by a dermatophyte. Onychomycosis is most prevalent in the toenails of adults and is more commonly found in patients with certain comorbid diseases such as diabetes, tinea pedis, and psoriasis. Management of onychomycosis includes a multispecialty team of healthcare providers. Early treatment of this infection, and new topical therapies are providing expanded options so clinicians can individualize treatment for this difficult to manage condition.

Ask the Onychomycosis Expert, Part 2: Tips for Dermatologists and Podiatrists CME
How can you improve your management of patients with onychomycosis?
December 23, 2017
Ask the Onychomycosis Expert: Part 1-Tips for Primary Care Physicians, Nurse Practitioners, and Pharmacists CME/CE
How do you manage your patients with onychomycosis?
December 18, 2017
Before and After: Patient Cases in Onychomycosis CME/CE
How do you manage challenging cases of onychomycosis?
November 22, 2017
Onychomycosis and Diabetes: Patient Case Challenges CME/CE
Join Dr Joseph in managing these patients with diabetes and onychomycosis.
June 27, 2017
The Relevance of Clinical Data in Dermatologic Fungus: Closing the Gaps CME/CE
Get updates on the latest clinical data and their application in the management of patients with onychomycosis.
January 29, 2016
How the Care Team Concept Applies to the Management of Cutaneous Fungal Diseases CME/CE
Watch a team care approach in the management of a patient with onychomycosis and how it can apply to your clinical practice
January 14, 2016
Multidisciplinary Perspectives in Diagnosis and Treatment Selection in Dermatologic Fungus CME/CE
Our expert panel discusses multidisciplinary management of a patient with onychomycosis
November 19, 2015
Keeping Up to Date on Onychomycosis: 5 Things PCPs Should Know CME/CE
Watch Dr Jackson give an update on the need-to-know information for diagnosing and treating onychomycosis
October 29, 2015
Testing Your Decision-Making in Difficult Cases of Dermatologic Fungus CME/CE
How do you manage complicated cases of onychomycosis?
October 29, 2015
Challenging Cases in Onychomycosis CME
Test your diagnostic and treatment skills by reviewing 2 complex cases of onychomycosis.
March 26, 2015

Steering Committee Chair

Boni E. Elewski, MD
Professor, University of
Alabama, Birmingham

Steering Committee Members

Aditya K. Gupta, MD, PhD, FRCPC, FAAD, MBA
Professor, University of Toronto, Toronto, Ontario
Jeffrey M. Robbins, DPM
Professor of Podiatric Medicine; Director, Podiatry Services VACO; Kent State University College of Podiatric Medicine, Independence, Ohio
Dyanne P. Westerberg, DO
Associate Professor, Cooper Medical School of Rowan University, Camden, New Jersey

Tracey C. Vlahovic, DPM, FFPM RCPS (Glasg)
Associate Professor, Temple University School of Podiatric Medicine, Philadelphia, Pennsylvania
Antonella Tosti, MD
Professor, Department of Dermatology & Cutaneous Surgery, University of Miami, Miami, Florida

Supported by an independent educational
grant from

Valeant Pharmaceuticals
North America LLC

Downloadable Slide Kit

A Primer on the Management of Patients With Onychomycosis
A briefing on risk factors for onychomycosis, diagnosis and treatment, when to refer to a specialist, and tips on patient education

Clinical Articles

Steering Committee

Boni E. Elewski, MD

Boni E. Elewski, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Anacor Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Valeant Pharmaceuticals International
Received grants for clinical research from: AbbVie Inc.; Amgen, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Valeant Pharmaceuticals International

Aditya K. Gupta, MD, PhD, FRCPC, FAAD, MBA

Aditya K. Gupta, MD, PhD, FRCPC, FAAD, MBA, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Anacor Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Moberg Pharma; Valeant Pharmaceuticals International
Received grants for clinical research from: Valeant Pharmaceuticals International
Clinical trials investigator: Lilly; Merck & Co., Inc.; UCB Pharma, Inc.

Jeffrey M. Robbins, DPM

Jeffrey M. Robbins, DPM, has disclosed no relevant financial relationships.

Tracey C. Vlahovic, DPM, FFPM RCPS (Glasg)

Tracey C. Vlahovic, DPM, FFPM RCPS (Glasg), has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Pharmaderm; Valeant Pharmaceuticals International

Antonella Tosti, MD

Antonella Tosti, MD has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Anacor Pharmaceuticals, Inc.; PharmaDerm; Polichem; Valeant Pharmaceuticals International; Viamet Pharmaceuticals Holdings, LLC
Served as a speaker or a member of a speakers bureau for: PharmDerm; Sandoz

Dyanne P. Westerberg, DO

Dyanne P. Westerberg, DO, has disclosed no relevant financial relationships.

	What percentage of your patients who are diagnosed with onychomycosis has diabetes?
		Less than 25%
		26% to 50%
		51% to 75%
		Greater than 75%